	Isolated limb perfusion
Melphalan
Late morbidity
Amputation
Tumor necrosis factor alpha
Sarcoma
Radiotherapy
	limb salvage
critical leg ischemia
perfusion
amputation
local recurrence
melphalan
adjuvant radiotherapy
tumor
patients
resection margins
survival
distant metastases
pathological examination
ILP
tumor necrosis factor alpha
radiotherapy
treatment
late morbidity
years
months
follow-up
necrosis
response
recurrent disease
locally
limb
results
pathological fracture
disease
time periods
radiation
skin
resection

